Comparison of Serum Concentrations of Ustekinumab Obtained by Three Commercial Assays in Patients with Crohn’s Disease
Author(s) -
Christine Verdon,
Niels Vande Casteele,
Valérie Heron,
Pascale Germain,
Waqqas Afif
Publication year - 2020
Publication title -
journal of the canadian association of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 2515-2092
pISSN - 2515-2084
DOI - 10.1093/jcag/gwaa003
Subject(s) - medicine , confidence interval , antibody , immunoassay , intraclass correlation , gastroenterology , immunology , pharmacology , chromatography , chemistry , reproducibility
Data on the association of ustekinumab (UST) drug concentrations and clinical outcomes are conflicting. We assessed serum UST drug and anti-UST antibody concentrations using three commercially available assays.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom